Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/11/2014US8669260 Ketoconazole-derivative antagonist of human pregnane X receptor and uses thereof
03/11/2014US8669259 Heterocyclic amide compounds as protein kinase inhibitors
03/11/2014US8669258 Treatment for gastroparesis using sepiapterin
03/11/2014US8669257 Phenazine derivatives and uses thereof as potassium channel modulators
03/11/2014US8669256 Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity
03/11/2014US8669255 Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
03/11/2014US8669253 Methods for treating glaucoma and macular degeneration
03/11/2014US8669252 Prolylcarboxypeptidase inhibitors
03/11/2014US8669251 8-fluorophthalazin-1(2H)-one compounds
03/11/2014US8669250 Derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
03/11/2014US8669249 Poly (ADP-ribose) polymerase (PARP) inhibitors
03/11/2014US8669248 Adenine inhibitors of HSP90
03/11/2014US8669247 2,5-disubstituted arylsulfonamide CCR3 antagonists
03/11/2014US8669246 Substituted amide compound
03/11/2014US8669245 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
03/11/2014US8669244 Cucurbitane-triterpenoid compounds, pharmaceutical composition, use and preparation method thereof
03/11/2014US8669243 Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
03/11/2014US8669242 Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
03/11/2014US8669241 Ophthalmic composition
03/11/2014US8669240 Biological specimen collection and transport system and method of use
03/11/2014US8669238 Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis
03/11/2014US8669234 Antiviral compounds
03/11/2014US8669233 Combination of compounds for treating or preventing skin diseases
03/11/2014US8669232 Flavonol compounds, a bioactive extract/fraction from Ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders
03/11/2014US8669210 High-strength, low viscosity herbicidal concentrate of clopyralid dimethylamin
03/11/2014US8669207 Compounds and compositions
03/11/2014US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
03/11/2014US8669084 Functional lipid constructs
03/11/2014US8668937 Topical nitric oxide systems and methods of use thereof
03/11/2014US8668934 Pharmaceutical formulation comprising a water-insoluble active agent
03/11/2014US8668932 Extended release venlafaxine formulation
03/11/2014US8668931 Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/11/2014US8668925 Transdermal delivery of hormones without the need of penetration enhancers
03/11/2014US8668921 Lipase inhibitors
03/11/2014US8668913 Complementary personal lubricant compositions
03/11/2014US8668901 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/11/2014CA2748620C Naltrexone hydrochloride compositions
03/11/2014CA2743483C Tetrasubstituted pyridazine hedgehog pathway antagonists
03/11/2014CA2726686C Triazole derivatives useful for the treatment of diseases
03/11/2014CA2691056C Bromo-phenyl substituted thiazolyl dihydropyrimidines for treating and preventing hepatitis b infections
03/11/2014CA2674780C Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
03/11/2014CA2672971C Stabilized sulforaphane
03/11/2014CA2655801C Therapeutic or prophylactic agent for leukemia
03/11/2014CA2647871C Method and system for determining whether a drug will be effective on a patient with a disease
03/11/2014CA2646667C Methods of treating hot flashes with formulations for transdermal or transmucosal application
03/11/2014CA2631390C Phenoxy acetic acids as ppar delta activators
03/11/2014CA2625553C Method for treating neuronal and non-neuronal pain
03/11/2014CA2624383C Salts of modulators of ppar and methods of treating metabolic disorders
03/11/2014CA2618638C Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
03/11/2014CA2617828C Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation methodthereof and use of same in
03/11/2014CA2608493C Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor
03/11/2014CA2605791C Bioabsorbable device having encapsulated additives for accelerating degradation
03/11/2014CA2599150C Anticancer agent comprising paclitaxel and a diptheria toxin mutant, crm 197
03/11/2014CA2573000C Composition containing statins and omega-3 fatty acids
03/11/2014CA2530598C Methods of treating acne and rosacea with galvanic generated electricity
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/11/2014CA2486127C Method of treating dyslipidemic disorders
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/10/2014CA2826708A1 Excipient system for topical delivery of pharmaceutical agents
03/06/2014WO2014036556A2 Drug delivery systems and methods for treatment of prostate
03/06/2014WO2014036555A1 Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
03/06/2014WO2014036548A1 Macromolecular prodrugs for hard tissue and methods of use thereof
03/06/2014WO2014036534A1 Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
03/06/2014WO2014036502A2 Tetracycline compounds
03/06/2014WO2014036445A2 Novel mucolytic agents
03/06/2014WO2014036443A2 Heterocyclyl carboxamides for treating viral diseases
03/06/2014WO2014036429A1 Mirna modulators of chronic visceral inflammation
03/06/2014WO2014036427A1 Biotin complexes for treatment and diagnosis of alzheimer's disease
03/06/2014WO2014036426A1 N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl) acetamide as protein|tyrosine kinase modulators
03/06/2014WO2014036414A2 Iron chelators and use thereof for reducing transplant failure
03/06/2014WO2014036395A1 SMALL MOLECULES TARGETING REPEAT r(CGG) SEQUENCES
03/06/2014WO2014036379A2 Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
03/06/2014WO2014036323A1 Method and composition for treating hyperglycemia
03/06/2014WO2014036309A1 Compositions and methods for drug-sensitization or inhibition of a cancer cell
03/06/2014WO2014036268A2 Indole derivatives as sumo activators
03/06/2014WO2014036244A1 Methods of administering a 5,5-fused heteroarylene hepatitis c virus inhibitor for treating of preventing hepatitis c virus infection
03/06/2014WO2014036242A2 Benzothiazole or benzoxazole compounds as sumo activators
03/06/2014WO2014036210A1 Foot implant and method for treating plantar fasciitis
03/06/2014WO2014036105A2 Inhibitors of memapsin 2 cleavage for the treatment of alzheimer's disease
03/06/2014WO2014036056A1 Crystalline forms of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone
03/06/2014WO2014036038A1 Lpa2 receptor-specific benzoic acid derivatives
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2014036016A1 Benzimidazole derivatives as itk inhibitors
03/06/2014WO2014036015A1 Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases
03/06/2014WO2014035971A2 Chlorhexidine gluconate solubilized in a hydrophobic monoacylglyceride
03/06/2014WO2014035967A2 Antagonists of chemokine receptors
03/06/2014WO2014035961A1 Composition and use for increasing t cells
03/06/2014WO2014035945A1 Pharmaceutical compositions
03/06/2014WO2014035872A1 Tricyclic alkynes that interact with glucokinase regulatory protein
03/06/2014WO2014035860A1 Inhibitors of beta-secretase
03/06/2014WO2014035846A2 Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
03/06/2014WO2014035829A1 Substituted 3-aminothieno[2,3-c]pyridine-2-carboxamide analogs as positive allosteric modulators
03/06/2014WO2014035827A1 Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
03/06/2014WO2014035707A1 Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness
03/06/2014WO2014035484A1 Compositions and methods for inhibiting activity of hypoxia-inducible transcription factor complex and its use for treatment of tumors
03/06/2014WO2014035465A1 The controlled release method for a pharmaceutical composition composed of chelating complex micelles
03/06/2014WO2014035451A1 Ophthalmic compositions with wax esters
03/06/2014WO2014035450A1 Ophthalmic compositions with omega-3 fatty acids
03/06/2014WO2014035446A1 Methods and compositions for hypotensive resuscitation
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 7860